MedTrace Logo

Cardiovascular Risk Factors in an Ambulatory Urban Patient Population

NCT00486993 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18287

Last updated 2016-11-08

No results posted yet for this study

Summary

According to WHO estimations, cardiovascular diseases (CVDs) are the number one cause of death globally. More people die annually from CVDs than from any other cause. An estimated 17.5 million people died from CVDs in 2005, representing 30% of all global deaths. Of these deaths, an estimated 7.6 million were due to coronary heart disease and 5.7 million were due to stroke.

Over 80% of CVD deaths take place in low- and middle-income countries and occur almost equally in men and women. In Paraguay, prevalence of classic risk factors, as well as new ones, like the metabolic syndrome are not completely known.

Government health policies in industrialized countries are focusing on programs to modify cardiovascular risk factors. In developing countries, prevention of coronary heart disease and stroke through modification of cardiovascular risk factors are not playing a large role at the moment.

The aim of this study is to define the effects of changes in lifestyle on cardiovascular risk factors, when added to optimized standard pharmacological therapy for arterial hypertension, diabetes mellitus and hyperlipidemia, in an ambulatory urban patient population.

Conditions

Interventions

BEHAVIORAL

Dietary and nutritional modification

BEHAVIORAL

Stop smoking

BEHAVIORAL

Regular physical activities

BEHAVIORAL

Weight reduction to normal ranges

BEHAVIORAL

Regular intake of polyphenols, esp. from Ilex paraguayensis

Sponsors & Collaborators

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Derliz Mereles, MD · Heidelberg University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • Paraguay

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00486993 on ClinicalTrials.gov